Due to ongoing labour disputes, Canada Post services will be suspended, which may impact some of our FIT and Integrative Laboratory Services (ILS) clients. Read more
Back to Test Catalogue

Neuromyelitis Optica Spectrum Disorder (NMOSD) Panel, Serum; test site SJH

Test ID: NMOG S

Test

Aliases/Synonyms

Anti-MOG; MOG Antibodies; Neuromyelitis Optica (NMO) Antibodies; Anti-NMO; Anti-Aquaporin 4

Method

Cell-Based Indirect Immunofluorescence

Report Includes

Aquaporin 4 Antibodies; Myelin-Oligodendrocyte Glycoprotein Antibodies (Anti-MOG)

Specimens

Serum

Clinical Utility

Many cases of Neuromyelitis Optica-spectrum disorders (NMOSD) are misdiagnosed as Multiple Sclerosis. As correct diagnosis is critical for prognosis, optimal treatment and prediction of relapse, initial testing for both Aquaporin 4 (AQP4) Antibodies and Myelin-Oligodendrocyte Glycoprotein (MOG) Antibodies is strongly recommended for new cases of NMOSD- see separate test listings. AQP4 antibodies are detected in about 80% of patients with NMO. Of these seronegative AQP-4 cases 7% will harbour MOG antibodies. Patients very rarely harbour both antibodies.

Test Location

St. Joseph's Hospital, 30 The Queensway, Toronto ON M6R 1B5

Test Version

29-Aug-2024

Specimen

Specimens

Serum

Sample Volume

2.0 mL

Minimum Volume

1.0 mL

Collection & Handling

Handling Information

Separate as soon as possible. Store and send frozen.

Stability

Ambient 6 hours
Refrigerated 14 days
Frozen 60 days

Test Version

29-Aug-2024

Performance / Interpretation

Method

Cell-Based Indirect Immunofluorescence

Turnaround Time

12 days

Results

Name Units Reference Range Conversion Factor
Aquaporin 4 Antibodies
  • Negative
Results of 1+ to 4+ indicate the presence of this autoantibody in increasing titers
Myelin-Oligodendrocyte Glycoprotein Antibodies (Anti-MOG)
  • Negative
Low Positive (1:10): Positive at 1:10 dilution and Negative at 1:100 dilution, indicating an endpoint titre that is between 1:10 and 1:100.
Clear Positive (1:100): Positive at 1:10 dilution and Positive at 1:100 dilution, indicating an endpoint titre that is greater than or equal to 1:100.

Test Location

St. Joseph's Hospital, 30 The Queensway, Toronto ON M6R 1B5

Test Version

29-Aug-2024

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
NMOG S 62782Anti Aquaporin 4 (NMO)
62783Anti MOG

Test Version

29-Aug-2024